• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM Back to Search Results
Catalog Number 07027559190
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/09/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The analyzer serial number is (b)(6).The investigation is ongoing.
 
Event or Problem Description
There was an allegation of questionable elecsys insulin results for 1 patient sample on a cobas e 801 analytical unit compared to an abbott alinity analyzer.The e801 result was 0.4 uiu/ml.The doctor questioned the result as it did not match the patient's clinical status.The sample was repeated on the alinity analyzer and the result was 20 uiu/ml.The sample was repeated again on another e801 analyzer and the result was 0.2 uiu/ml.
 
Additional Manufacturer Narrative
Section d10, concomitant medical products, was updated.The patient had a low c-peptide result (0.1 ng/ml), which confirms the low roche insulin result.The patient takes glargine and aspart insulin.Treated insulin analogues are not recognized by the elecsys assay, in contrast to the competitor abbott assay.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS INSULIN
Common Device Name
IMMUNOREACTIVE INSULIN TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key23416804
Report Number1823260-2025-04411
Device Sequence Number16054253
Product Code CFP
UDI-Device Identifier04015630940042
UDI-Public04015630940042
Combination Product (Y/N)N
Initial Reporter CountrySA
PMA/510(K) Number
K001104
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2025
Device Catalogue Number07027559190
Device Lot Number81105901
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/09/2025
Supplement Date Received by Manufacturer11/03/2025
Initial Report FDA Received Date10/29/2025
Supplement Report FDA Received Date11/24/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ASPART; GLARGINE
Patient Age10 YR
Patient SexFemale
-
-